NIKKEI 225
31,738.00 -134.52 (-0.42%) HANG SENG
17,829.02 +455.99 (+2.62%) CRUDE OIL
91.77 +0.06 (+0.07%) GOLD FUTURES
1,881.30 +2.70 (+0.14%) DOW
33,666.34 +116.07 (+0.35%) Bitcoin GBP
22,068.57 +459.73 (+2.13%)
Indivior PLC (INDV.L)
| Previous close | 1,760.00 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 420,130 |
| Market cap | 2.491B |
| Beta (5Y monthly) | 0.00 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.33 |
| Earnings date | 27 Jul 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 16 Jun 2016 |
| 1y target est | 24.46 |
ZacksIndivior PLC (INDV) is on the Move, Here's Why the Trend Could be Sustainable
Indivior PLC (INDV) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
ReutersIndivior to pay $30 million to settle health plans' Suboxone claims
Indivior has agreed to pay $30 million to settle a class action lawsuit filed in a U.S. court by health plans accusing the drugmaker of illegally suppressing generic competition for its opioid addiction treatment Suboxone. The settlement, disclosed on Saturday in a filing by lawyers for the health plans in federal court in Philadelphia, must still be approved by a judge. Indivior is still facing claims by drug wholesalers that bought Suboxone from the Virginia-based company directly, with a trial scheduled in October.
Simply Wall St.The 7.5% return this week takes Indivior's (LON:INDV) shareholders three-year gains to 372%
For us, stock picking is in large part the hunt for the truly magnificent stocks. You won't get it right every time...
